{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:34:23Z","timestamp":1794501263080,"version":"4.9.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100008091","name":"University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UO1 HL096607"],"award-info":[{"award-number":["UO1 HL096607"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UO1 HL096610"],"award-info":[{"award-number":["UO1 HL096610"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The benefit of prophylactic implantable cardioverter-defibrillator (ICD) is not uniform due to differences in the risk of life-threatening ventricular tachycardia (VT)\/ventricular fibrillation (VF) and non-arrhythmic mortality. We aimed to develop an ICD benefit prediction score that integrates the competing risks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>The study population comprised all 4531 patients enrolled in the MADIT trials. Best-subsets Fine and Gray regression analysis was used to develop prognostic models for VT (\u2265200 b.p.m.)\/VF vs. non-arrhythmic mortality (defined as death without prior sustained VT\/VF). Eight predictors of VT\/VF (male, age\u2009&amp;lt;\u200975 years, prior non-sustained VT, heart rate\u2009&amp;gt;\u200975 b.p.m., systolic blood pressure\u2009&amp;lt;\u2009140\u2009mmHg, ejection fraction\u2009\u2264\u200925%, myocardial infarction, and atrialarrhythmia) and 7 predictors of non-arrhythmic mortality (age\u2009\u2265\u200975 years, diabetes mellitus, body mass index\u2009&amp;lt;\u200923\u2009kg\/m2, ejection fraction\u2009\u2264\u200925%, New York Heart Association \u2265II, ICD vs. cardiac resynchronization therapy with defibrillator, and atrial arrhythmia) were identified. The two scores were combined to create three MADIT-ICD benefit groups. In the highest benefit group, the 3-year predicted risk of VT\/VF was three-fold higher than the risk of non-arrhythmic mortality (20% vs. 7%, P\u2009&amp;lt;\u20090.001). In the intermediate benefit group, the difference in the corresponding predicted risks was attenuated (15% vs. 9%, P\u2009&amp;lt;\u20090.01). In the lowest benefit group, the 3-year predicted risk of VT\/VF was similar to the risk of non-arrhythmic mortality (11% vs. 12%, P\u2009=\u20090.41). A personalized ICD benefit score was developed based on the distribution of the two competing risks scores in the study population (https:\/\/is.gd\/madit). Internal and external validation confirmed model stability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We propose the novel MADIT-ICD benefit score that predicts the likelihood of prophylactic ICD benefit through personalized assessment of the risk of VT\/VF weighed against the risk of non-arrhythmic mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaa1057","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T20:10:14Z","timestamp":1607803814000},"page":"1676-1684","source":"Crossref","is-referenced-by-count":130,"title":["Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-5025","authenticated-orcid":false,"given":"Arwa","family":"Younis","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J","family":"Goldberger","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Miller School of Medicine, University of Miami , 1321 NW 14th St #510, Miami, FL 33125, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-289X","authenticated-orcid":false,"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronislava","family":"Polonsky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-4654","authenticated-orcid":false,"given":"Helmut","family":"Klein","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet K","family":"Aktas","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-9219","authenticated-orcid":false,"given":"James","family":"Daubert","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke Medicine Circle Clinic 2F\/2G, Durham, NC 27710, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Estes","sequence":"additional","affiliation":[{"name":"Division of Cardiology, UPMC Heart and Vascular Institute 1350 Locust Street, Suite 100 Pittsburgh, PA 15219, \u00a0 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cannom","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Good Samaritan Hospital , 1245 Wilshire Blvd, Ste 703, Los Angeles, CA 90017, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Stein","sequence":"additional","affiliation":[{"name":"Cardiac Rhythm Management, Boston Scientific Corp. , 4100 Hamline Ave N, St Paul, MN 55101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center , 265 Crittenden Blvd CU 420653, NY 14642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"2022102514350498300_ehaa1057-B1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18560","article-title":"Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation","volume":"18","author":"Colquitt","year":"2014","journal-title":"Health Technol Assess"},{"key":"2022102514350498300_ehaa1057-B4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B6","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B7","author":"Zareba"},{"key":"2022102514350498300_ehaa1057-B8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial","volume":"72","author":"Zareba","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102514350498300_ehaa1057-B9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"2022102514350498300_ehaa1057-B10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ahj.2008.08.016","article-title":"Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"157","author":"Ni","year":"2009","journal-title":"Am Heart J"},{"key":"2022102514350498300_ehaa1057-B11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cardfail.2017.03.007","article-title":"The inescapable heterogeneity of heart failure","volume":"23","author":"Lund","year":"2017","journal-title":"J Card Fail"},{"key":"2022102514350498300_ehaa1057-B12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.12688\/f1000research.7022.1","article-title":"Recent advances in treatment of heart failure","volume":"4","author":"Kitai","year":"2015","journal-title":"F1000Res"},{"key":"2022102514350498300_ehaa1057-B13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102514350498300_ehaa1057-B14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022102514350498300_ehaa1057-B15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"2022102514350498300_ehaa1057-B16","first-page":"2606","article-title":"Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","author":"Bilchick","year":"2017"},{"key":"2022102514350498300_ehaa1057-B17","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.117.033427","article-title":"Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study","volume":"137","author":"Tseng","year":"2018","journal-title":"Circulation"},{"key":"2022102514350498300_ehaa1057-B18","first-page":"1843","article-title":"Death with an implantable cardioverter-defibrillator: a MADIT-II substudy","volume":"21","author":"Chernomordik","year":"2019","journal-title":"Europace"},{"key":"2022102514350498300_ehaa1057-B19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/europace\/eun253","article-title":"Impact of advanced age on survival in patients with implantable cardioverter defibrillators","volume":"10","author":"Pellegrini","year":"2008","journal-title":"Europace"},{"key":"2022102514350498300_ehaa1057-B20","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102514350498300_ehaa1057-B21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ahj.2005.03.066","article-title":"Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function","volume":"151","author":"Ahmed","year":"2006","journal-title":"Am Heart J"},{"key":"2022102514350498300_ehaa1057-B22","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ahj.2008.08.007","article-title":"Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"156","author":"Gula","year":"2008","journal-title":"Am Heart J"},{"key":"2022102514350498300_ehaa1057-B23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCULATIONAHA.106.679779","article-title":"Body mass index and prognosis in patients with chronic heart failure","volume":"116","author":"Kenchaiah","year":"2007","journal-title":"Circulation"},{"key":"2022102514350498300_ehaa1057-B24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1503\/cmaj.101685","article-title":"Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials","volume":"183","author":"Wells","year":"2011","journal-title":"CMAJ"},{"key":"2022102514350498300_ehaa1057-B25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejheart.2008.07.002","article-title":"Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis","volume":"10","author":"de Sousa","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2022102514350498300_ehaa1057-B26","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2006.11.042","article-title":"Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"49","author":"Goldenberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102514350498300_ehaa1057-B27","doi-asserted-by":"crossref","first-page":"e005680","DOI":"10.1161\/CIRCEP.117.005680","article-title":"Sex differences in cardiac arrhythmias: clinical and research implications","volume":"11","author":"Ehdaie","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102514350498300_ehaa1057-B28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.111.962597","article-title":"High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation","volume":"5","author":"Olesen","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"2022102514350498300_ehaa1057-B29","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102514350498300_ehaa1057-B30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102514350498300_ehaa1057-B31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/europace\/euw408","article-title":"The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers","volume":"20","author":"Ruwald","year":"2018","journal-title":"Europace"},{"key":"2022102514350498300_ehaa1057-B32","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","article-title":"Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation","volume":"67","author":"Roth","year":"2016","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/17\/1676\/46625812\/ehaa1057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/17\/1676\/46625812\/ehaa1057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T17:22:40Z","timestamp":1666718560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/17\/1676\/6071721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,1,8]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1057","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,1,8]]}}}